Du är här

2014-05-12

Vida Cannabis Corp.: Vida Cannabis (Canada) Files Licensed Commercial Producer Application With Health Canada

Toronto, Ontario - May 12, 2014 - Vida Cannabis Corp.
("Vida Cannabis") is pleased to announce that its wholly owned subsidiary Vida
Cannabis (Canada) Ltd. ("Vida Canada") submitted its application to become a
licensed commercial producer for its 300,000-plus-square-foot medical
marijuana production facility in Stellarton, Nova Scotia under theMarihuana
for Medical Purposes Regulations
("MMPR"). The 600-plus-page treatise was sent to Health Canada on May 5, 2014.

The conditions that must be met before the issuance of a licence are
understandably extensive due to the potential public health, safety and
security risks involved in the production and distribution of medical
marijuana. Health Canada requires potential producers to provide detailed
measures related to security, good production practices, packaging, labelling
and shipping, record keeping and reporting and distribution. In addition, all
key personnel, directors and officers must hold a valid enhanced security
clearance.

Vida Canada's management, legal and consulting teams contributed an
overwhelming amount of knowledge, expertise, time and effort in preparing the
application package and reviewing the MMPR, other applicable legislation and
policy guidelines to ensure the strictest compliance. In line with Vida's
guiding principles, all plans were prepared to ensure that Vida Canada not
only fulfills all the mandatory requirements, but surpasses the required
standards whenever possible, as it aspires to have the best cultivation
facility, security and operational systems in place.

Greg Wilson, Vida's Chairman and CEO, stated: "The submission of our
application package is a critical milestone in Vida Canada's journey towards
licensure. Moreover, I feel incredibly fortunate to have worked with the
people I consider to be the best in the business in preparing our
application."

In the application, Vida Canada enumerated the activities it wishes to conduct
with marijuana and the purpose for conducting those activities. As mandated,
in order to allow Health Canada to assess whether Vida Canada has the key
measures in place, it prepared and provided the following:

1 Security

Vida Canada's Responsible Person in Charge and Chief Operating Officer, Mr.
Derek Ogden, prepared a thorough security plan that covered the physical
security requirements for the entire Stellarton site and facility, as well as
for the storage of dried marijuana. Vida Canada's goal is to design a
facility guided by the stricter rules imposed upon pharmaceutical
manufacturers. Vida Canada plans to implement level 10 security and in some
instances even level 11 measures, whereas the mandatory level is a level 7
and 8. The quality and level of detail of the security plan section of the
application was achievable only through the experience and knowledge Mr.
Ogden amassed during his tenure with the RCMP that spanned nearly 27 years,
serving in capacities that included Chief Superintendent, Officer in Charge
of Drug Enforcement and Director General of the Drugs and Organized Crime
branch.

1 Quality Assurance

This section was written by Mr. Pritesh Kumar, Vida Canada's Quality Assurance
Manager and Chief Cannabinoid Research Scientist, who possesses in-depth
training and experience in the area of Quality Assurance/Control, Good
Manufacturing Practices and Good Production Practices. He provided a
comprehensive quality assurance report that demonstrates that the facility,
equipment and proposed sanitation program to be used meet the criteria of the
MMPR.

1 Record Keeping

Vida Canada provided a comprehensive record keeping manual, which includes a
description of the multi-layered, full-service record keeping software
application designed by Quantum 9, Inc. to be implemented by Vida Canada.
Quantum 9, Inc. is North America's pre-eminent authority on cannabis
cultivation consulting and technology services. The software application is
the product of countless hours of research and development. Furthermore, the
proposed methods are specifically designed to comply with all MMPR
requirements. Although not obligatory, Vida Canada was also able to present
sample forms of its record keeping documentation to support the record
keeping plan submitted.

Overall, the package Vida Canada prepared was designed to be a comprehensive
working model for the operations of the business. There were a number of
inclusions of very detailed Good Production Practices and Standard Operating
Procedures to demonstrate Vida Canada's intent to exceed all statutory
requirements. The site plan designs were exhaustive, providing visuals of the
measures described. Vida Canada was able to demonstrate strong local support
evidenced by letters from the local municipal government, business community
and local residents. Vida intends on becoming the international standard
bearer for the commercial production of medical marijuana.

About Vida Cannabis Corp.

Vida Cannabis Corp. ("Vida Cannabis") is focused on developing a dominant
production footprint in the rapidly developing global marketplace for the
legal use of medicinal and recreational marijuana.

Initial operations are focused on the Canadian market where Health Canada has
established national guidelines enabling best-in-class producers to acquire
commercial production licenses under theMarihuana for Medical Purposes
Regulations
.

Via its wholly owned subsidiary, Vida Cannabis (Canada) Ltd., Vida Cannabis
purchased a 300,000-plus-square-foot production facility in the town of
Stellarton, Nova Scotia and secured a 50-year irrevocable approval
unanimously from the local municipality to operate a medical marijuana
production plant at the facility.

The highly secure facility boasts a fully engineered concrete floor,
18-foot-high concrete walls and a steel roof making it an ideal location for
the construction of a customized, state-of-the-art modern medical marijuana
production plant.

Vida Cannabis is working with one of the most experienced cannabis consulting
teams in the world, Chicago-based Quantum 9 Inc., which has extensive
resources in the United States, Canada and Europe, to establish an optimized
end-to-end production plan to help position Vida Cannabis with the largest,
most advanced medical marijuana facility in Canada.

Vida Cannabis continues to evaluate additional potential markets as regulatory
bodies around the world pass legislation enabling the production and
distribution of medicinal or recreational marijuana.

On behalf of the board,

Greg Wilson - Chairman&CEO

Vida Cannabis Corp.

Investor Services

Toll free: +1 800 593 1585

Direct: +1 647 560 4482

Email:InvestorServices@VidaCannabis.com

Web:VidaCannabis.com

Disclaimer

This announcement does not constitute or form part of, and shall under no
circumstances be considered as, an offer to sell, a solicitation to purchase,
or advice on investments in any securities of Vida Cannabis Corp. ("Vida
Cannabis"). Offers and solicitations shall be expressly identified as such
and made in compliance with applicable securities laws. This announcement is
for information purposes only. It should not be relied upon as a basis for
investment decisions. You should consult with your own investment,
accounting, legal and tax advisers to evaluate independently the risks,
consequences and suitability of any investments you are considering. Whilst
the information provided here is believed to be reliable, it cannot be
guaranteed. It may contain forward-looking statements made by or on behalf of
Vida Cannabis about its business or financial objectives, position,
strategies or expectations. Such forward-looking statements may be identified
by words such as, or similar to, "intends," "anticipates," "believes,"
"expects" and "hopes" and includes, without limitation, the development of
production facilities, approval from regulatory authorities and the ability
for Vida Cannabis to obtain adequate financing to meet its business
objectives. These statements involve inherent risks and uncertainties that
could cause actual results to differ materially from those indicated. The
statements in this announcement do not guarantee future performance. Vida
Cannabis does not undertake any obligation to update any information provided
in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned
subsidiary of Vida Cannabis, must obtain approval from Health Canada in order
to operate as a licensed commercial producer under theMarihuana for Medical
Purposes Regulations
. Vida Cannabis makes no representations or warranties that it will receive
Health Canada approval.

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vida Cannabis Corp. via Globenewswire

HUG#1784547

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.